Skip to main content
. 2020 Jun 13;2020(6):CD013646. doi: 10.1002/14651858.CD013646
Antimicrobial agents Community‐acquired biliary infection HeaIthcare‐associated biliary infection
Grade I
Cholecystitis and cholangitis
Grade II
Cholecystitis and cholangitis
Grade III
Cholecystitis and cholangitis
Cholecystitis and cholangitis
Penicillin‐based therapy Ampicillin/sulbactam Piperacillin/tazobactam Piperacillin/tazobactam Piperacillin/tazobactam
Cephalosporin‐based therapy Cefazolin,
or cefuroxime,
or ceftriaxone,
or cefotaxime
± metronidazole,
cefmetatole, cefoxitin
flomoxef, cefoperazone/sulbactam
Ceftriaxone,
or cefotaxime,
or cefepime,
or cefozopran,
or ceftazidime,
± metronidazole,
cefoperazone/sulbactam
Cefepime,
or ceftazidime,
or cefoperazon
± metronidazole
Cefepime,
or ceftazidime,
or cefoperazon
± metronidazole
Carbapenem‐based therapy Ertapenem Ertapenem Imipenem/cilastatin, meropenem, doripenem, ertapenem Imipenem/cilastatin, meropenem, doripenem, ertapenem
Monobactam‐based therapy Aztreonam ± metronidazole Aztreonam ± metronidazole
Fluoroquinolone‐based therapy Ciprofloxacin, levofloxacin, pazufloxacin ± metronidazole, moxifloxacin Ciprofloxacin, levofloxacin,
pazufloxacin ± metronidazole,
moxifloxacin